Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.
Grant-McAuley W, Morgenlander W, Hudelson SE, Thakar M, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Wilson E, Ayles H, Bock P, Moore A, Kosloff B, Shanaube K, Meehan SA, van Deventer A, Fidler S, Hayes R, Ruczinski I, Kammers K, Laeyendecker O, Larman HB, Eshleman SH. Grant-McAuley W, et al. Among authors: hudelson se. Front Immunol. 2023 Sep 6;14:1178520. doi: 10.3389/fimmu.2023.1178520. eCollection 2023. Front Immunol. 2023. PMID: 37744365 Free PMC article. Clinical Trial.
HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression.
Kammers K, Chen A, Monaco DR, Hudelson SE, Grant-McAuley W, Moore RD, Alter G, Deeks SG, Morrison CS, Eller LA, Blankson JN, Laeyendecker O, Ruczinski I, Eshleman SH, Larman HB. Kammers K, et al. Among authors: hudelson se. Front Immunol. 2021 Aug 26;12:740395. doi: 10.3389/fimmu.2021.740395. eCollection 2021. Front Immunol. 2021. PMID: 34512672 Free PMC article.
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
Grant-McAuley W, Laeyendecker O, Monaco D, Chen A, Hudelson SE, Klock E, Brookmeyer R, Morrison D, Piwowar-Manning E, Morrison CS, Hayes R, Ayles H, Bock P, Kosloff B, Shanaube K, Mandla N, van Deventer A, Ruczinski I, Kammers K, Larman HB, Eshleman SH. Grant-McAuley W, et al. Among authors: hudelson se. BMC Infect Dis. 2022 Nov 11;22(1):838. doi: 10.1186/s12879-022-07850-0. BMC Infect Dis. 2022. PMID: 36368950 Free PMC article.
Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.
Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gómez-Olivé FX, Hughes JP, Pettifor A, Eshleman SH. Zhang Y, et al. Among authors: hudelson se. J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):315-322. doi: 10.1097/QAI.0000000000001793. J Acquir Immune Defic Syndr. 2018. PMID: 29985265 Free PMC article.
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda.
Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH. Reynolds SJ, et al. Among authors: hudelson se. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1739-44. doi: 10.1089/aid.2011.0352. Epub 2012 Apr 26. AIDS Res Hum Retroviruses. 2012. PMID: 22443282 Free PMC article.
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.
Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH. Fogel JM, et al. Among authors: hudelson se. J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9. doi: 10.1097/QAI.0000000000000951. J Acquir Immune Defic Syndr. 2016. PMID: 26859828 Free PMC article. Clinical Trial.
Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.
Sivay MV, Li M, Piwowar-Manning E, Zhang Y, Hudelson SE, Marzinke MA, Amico RK, Redd A, Hendrix CW, Anderson PL, Bokoch K, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant R, Eshleman SH; HPTN 067/ADAPT Study Team. Sivay MV, et al. Among authors: hudelson se. J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):271-279. doi: 10.1097/QAI.0000000000001374. J Acquir Immune Defic Syndr. 2017. PMID: 28328548 Free PMC article. Clinical Trial.
35 results